Correlation Between Shinkong Insurance and Alar Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Shinkong Insurance and Alar Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Shinkong Insurance and Alar Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Shinkong Insurance Co and Alar Pharmaceuticals, you can compare the effects of market volatilities on Shinkong Insurance and Alar Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Shinkong Insurance with a short position of Alar Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Shinkong Insurance and Alar Pharmaceuticals.
Diversification Opportunities for Shinkong Insurance and Alar Pharmaceuticals
-0.78 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Shinkong and Alar is -0.78. Overlapping area represents the amount of risk that can be diversified away by holding Shinkong Insurance Co and Alar Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Alar Pharmaceuticals and Shinkong Insurance is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Shinkong Insurance Co are associated (or correlated) with Alar Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Alar Pharmaceuticals has no effect on the direction of Shinkong Insurance i.e., Shinkong Insurance and Alar Pharmaceuticals go up and down completely randomly.
Pair Corralation between Shinkong Insurance and Alar Pharmaceuticals
Assuming the 90 days trading horizon Shinkong Insurance Co is expected to generate 0.43 times more return on investment than Alar Pharmaceuticals. However, Shinkong Insurance Co is 2.35 times less risky than Alar Pharmaceuticals. It trades about 0.16 of its potential returns per unit of risk. Alar Pharmaceuticals is currently generating about -0.12 per unit of risk. If you would invest 9,200 in Shinkong Insurance Co on September 15, 2024 and sell it today you would earn a total of 1,100 from holding Shinkong Insurance Co or generate 11.96% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Shinkong Insurance Co vs. Alar Pharmaceuticals
Performance |
Timeline |
Shinkong Insurance |
Alar Pharmaceuticals |
Shinkong Insurance and Alar Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Shinkong Insurance and Alar Pharmaceuticals
The main advantage of trading using opposite Shinkong Insurance and Alar Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Shinkong Insurance position performs unexpectedly, Alar Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alar Pharmaceuticals will offset losses from the drop in Alar Pharmaceuticals' long position.Shinkong Insurance vs. Central Reinsurance Corp | Shinkong Insurance vs. Huaku Development Co | Shinkong Insurance vs. Fubon Financial Holding | Shinkong Insurance vs. Chailease Holding Co |
Alar Pharmaceuticals vs. APEX International Financial | Alar Pharmaceuticals vs. Chi Sheng Chemical | Alar Pharmaceuticals vs. Shinkong Insurance Co | Alar Pharmaceuticals vs. Cathay Financial Holding |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Other Complementary Tools
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |